Ascendis Pharma A/S Forecast and Stock Analysis
Technical ASND stock analysis for February 21, 2019.
Ascendis Pharma A/S fell by -1.44% in the last day from $69.98 to $68.97 and has now fallen 4 days in a row. The price has risen in 6 of the last 10 days and is up by 0.41% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -257 912 shares and in total 135 802 shares bought and sold for approximately $9.37 million.
Close price at the end of the last trading day (Thursday, 21st Feb 2019) of the ASND stock was $68.97. This is 1.44% less than the trading day before Wednesday, 20th Feb 2019.
During day the stock fluctuated 4.64% from a day low at $67.36 to a day high of $70.48.
30 day high of the ASND stock price was $75.68 and low was $66.12.
90 day high was $75.83 and low was $54.66.
52 week high for the Ascendis Pharma A/S - $76.99 and low - $53.21.
Ascendis Pharma A/S lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.09% during the next 3 months and, with 90% probability hold a price between $73.58 and $93.26 at the end of this period.
There are few to none technical positive signals at the moment. Ascendis Pharma A/S holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $70.67 and $70.35. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday February 15, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 42 and the stock is currently not being overbought or oversold
Support & Resistance
Ascendis Pharma A/S finds support from accumulated volume at $67.66.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $3.12 (4.64%) between high and low. For the last week, the stock has had a daily average volatility of 3.62%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Ascendis Pharma A/S stock holds several negative signals and despite the positive trend we believe Ascendis Pharma A/S will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.